BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 3 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $203,000 | -14.3% | 65,344 | -0.4% | 0.00% | – |
| Q3 2021 | $237,000 | +1.3% | 65,590 | +0.4% | 0.00% | – |
| Q2 2021 | $234,000 | -7.5% | 65,359 | +1.2% | 0.00% | – |
| Q1 2021 | $253,000 | -6.6% | 64,600 | 0.0% | 0.00% | – |
| Q4 2020 | $271,000 | +12.4% | 64,600 | 0.0% | 0.00% | – |
| Q3 2020 | $241,000 | -14.5% | 64,600 | 0.0% | 0.00% | – |
| Q2 2020 | $282,000 | +15.1% | 64,600 | 0.0% | 0.00% | – |
| Q1 2020 | $245,000 | -40.0% | 64,600 | 0.0% | 0.00% | – |
| Q4 2019 | $408,000 | +13.3% | 64,600 | -24.4% | 0.00% | – |
| Q3 2019 | $360,000 | -7.5% | 85,500 | +2.2% | 0.00% | – |
| Q2 2019 | $389,000 | +186.0% | 83,700 | +98.3% | 0.00% | – |
| Q1 2016 | $136,000 | -93.8% | 42,200 | -90.8% | 0.00% | -100.0% |
| Q4 2015 | $2,206,000 | -13.9% | 460,608 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $2,561,000 | -30.8% | 460,608 | -0.9% | 0.00% | -20.0% |
| Q2 2015 | $3,701,000 | +24.3% | 464,912 | +64.0% | 0.01% | +25.0% |
| Q1 2015 | $2,977,000 | – | 283,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |